Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 75

1.

[The effect of ivermectin on geohelminth frequency (i.e. as used in the onchocerciasis control program in Colombia)].

Knudson A, Ariza Y, López MC, Fajardo OS, Reyes P, Moncada LI, Duque S, Álvarez CA, Nicholls RS.

Rev Salud Publica (Bogota). 2012 Aug;14(4):681-94. Spanish.

2.

Impact of 3 years ivermectin treatment on onchocerciasis in Yanomami communities in the Brazilian Amazon.

Banic DM, Calvão-Brito RH, Marchon-Silva V, Schuertez JC, de Lima Pinheiro LR, da Costa Alves M, Têva A, Maia-Herzog M.

Acta Trop. 2009 Nov;112(2):125-30. doi: 10.1016/j.actatropica.2009.07.009. Epub 2009 Jul 15.

PMID:
19615327
3.

Onchocerciasis situation in the Tukuyu focus of southwest Tanzania after ten years of ivermectin mass treatment.

Mweya CN, Kalinga AK, Kabula B, Malley KD, Ruhiso MH, Maegga BT.

Tanzan Health Res Bull. 2007 Sep;9(3):174-9.

PMID:
18087895
4.

Adverse reactions from community directed treatment with ivermectin (CDTI) for onchocerciasis and loiasis in Ondo State, Nigeria.

Otubanjo OA, Adeoye GO, Ibidapo CA, Akinsanya B, Okeke P, Atalabi T, Adejai ET, Braide E.

Rev Biol Trop. 2008 Dec;56(4):1635-43.

PMID:
19419072
5.

Mass Administration of Ivermectin for the Elimination of Onchocerciasis Significantly Reduced and Maintained Low the Prevalence of Strongyloides stercoralis in Esmeraldas, Ecuador.

Anselmi M, Buonfrate D, Guevara Espinoza A, Prandi R, Marquez M, Gobbo M, Montresor A, Albonico M, Racines Orbe M, Martin Moreira J, Bisoffi Z.

PLoS Negl Trop Dis. 2015 Nov 5;9(11):e0004150. doi: 10.1371/journal.pntd.0004150. eCollection 2015 Nov.

6.

Concurrence of dermatological and ophthalmological morbidity in onchocerciasis.

Coffeng LE, Fobi G, Ozoh G, Bissek AC, Nlatté BO, Enyong P, Olinga JM, Zouré HG, Habbema JD, Stolk WA, de Vlas SJ, Boussinesq M, Noma M.

Trans R Soc Trop Med Hyg. 2012 Apr;106(4):243-51. doi: 10.1016/j.trstmh.2011.12.006. Epub 2012 Feb 17.

PMID:
22342170
7.

Prevalence of onchocerciasis in the Fundong Health District, Cameroon after 6 years of continuous community-directed treatment with ivermectin.

Kamga HL, Shey DN, Assob JC, Njunda AL, Nde Fon P, Njem PK.

Pan Afr Med J. 2011;10:34. Epub 2011 Nov 10.

8.

African Programme for Onchocerciasis Control: progress report, 2013-2014.

[No authors listed]

Wkly Epidemiol Rec. 2014 Dec 5;89(49):551-60. English, French. No abstract available.

PMID:
25485343
9.
10.

Successful elimination of onchocerciasis (river blindness) vectors from isolated foci in two African countries.

Brattig NW.

Acta Trop. 2009 Sep;111(3):201-2. doi: 10.1016/j.actatropica.2009.06.013. No abstract available.

PMID:
19619685
11.

[Elimination or control of the onchocerciasis in Africa? Case of Gami village in Central African Republic].

Yaya G, Kobangué L, Kémata B, Gallé D, Grésenguet G.

Bull Soc Pathol Exot. 2014 Aug;107(3):188-93. doi: 10.1007/s13149-014-0363-8. Epub 2014 May 10. French.

PMID:
24816795
12.

The Onchocerciasis Elimination Program for the Americas: a history of partnership.

Blanks J, Richards F, Beltrán F, Collins R, Alvarez E, Zea Flores G, Bauler B, Cedillos R, Heisler M, Brandling-Bennett D, Baldwin W, Bayona M, Klein R, Jacox M.

Rev Panam Salud Publica. 1998 Jun;3(6):367-74.

PMID:
9734217
13.

Effects of annual mass treatment with ivermectin for onchocerciasis on the prevalence of intestinal helminths.

Gutman J, Emukah E, Okpala N, Okoro C, Obasi A, Miri ES, Richards FO Jr.

Am J Trop Med Hyg. 2010 Sep;83(3):534-41. doi: 10.4269/ajtmh.2010.10-0033.

14.

The impact of ivermectin treatment alone and when in parallel with Simulium neavei elimination on onchocerciasis in Uganda.

Ndyomugyenyi R, Tukesiga E, Büttner DW, Garms R.

Trop Med Int Health. 2004 Aug;9(8):882-6.

15.

Proteinuria and onchocerciasis in an endemic area in Cameroon under community-based treatment with ivermectin.

Ebong CE, Alemnji GA; Mbuagbaw., Ashuntantang G, Asonganyi T.

Trop Doct. 2007 Jul;37(3):156-8.

PMID:
17716503
16.

Ivermectin does not reduce the burden of itching in an onchocerciasis endemic community.

Whitworth JA, Luty AJ, Maude GH, Morgan D, Downham MD, Taylor DW.

Trans R Soc Trop Med Hyg. 1992 May-Jun;86(3):281-3.

PMID:
1412653
17.

Feasibility of measuring compliance to annual ivermectin treatment in the African Programme for Onchocerciasis Control.

Brieger WR, Okeibunor JC, Abiose AO, Ndyomugyenyi R, Kisoka W, Wanji S, Elhassan E, Amazigo UV.

Trop Med Int Health. 2007 Feb;12(2):260-8.

18.

Operational lessons from 20 years of the Mectizan Donation Program for the control of onchocerciasis.

Thylefors B, Alleman MM, Twum-Danso NA.

Trop Med Int Health. 2008 May;13(5):689-96. doi: 10.1111/j.1365-3156.2008.02049.x. Review.

19.

Traditional kinship system enhanced classic community-directed treatment with ivermectin (CDTI) for onchocerciasis control in Uganda.

Katabarwa MN, Habomugisha P, Agunyo S, McKelvey AC, Ogweng N, Kwebiiha S, Byenume F, Male B, McFarland D.

Trans R Soc Trop Med Hyg. 2010 Apr;104(4):265-72. doi: 10.1016/j.trstmh.2009.10.012. Epub 2010 Jan 27.

PMID:
20106493
20.

Effect of repeated treatments with ivermectin on the incidence of onchocerciasis in northern Cameroon.

Boussinesq M, Chippaux JP, Ernould JC, Quillevere D, Prod'hon J.

Am J Trop Med Hyg. 1995 Jul;53(1):63-7.

PMID:
7625535

Supplemental Content

Support Center